Trulieve Cannabis Corp. will hold a first quarter 2022 results conference call on May 12, 2022

Select CBD Bites is formulated with natural ingredients and unique cannabinoids such as CBN, CBG, and CBD to target three specific areas: sleep, restoration, and recovery. Each bite contains 25mg of cannabinoids derived from US-grown hemp that have been lab-tested for purity and consistency by a third-party. Select CBD bites contain one of the widest assortments of cannabinoids on the market and are now available in three juicy flavors:

  • Select Snooze Bites (Blackberry) are infused with a 1:1 ratio of CBD and CBN, a cannabinoid known for its relaxing and sedative qualities.
  • Select Recover Bites (Watermelon) are infused with a 1:1 ratio of CBD and CBG, a cannabinoid known for its restorative qualities.
  • Select cold bites (Mango) are infused with CBD, one of the best-known non-psychoactive cannabinoids on the market known for its soothing qualities.

“For cannabis to become a true consumer CPG industry, we need to create accessible products that fit seamlessly into the lifestyles of everyday consumers,” said Joe Bayern , CEO of Curaleaf US. “Select CBD Bites reflects our mission to bring high-quality, accessible products to consumers at every stage of their cannabis journey, and we are excited to bring these offerings to a national audience.”

Last year, Curaleaf announced its national distribution agreement with Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the world’s largest distributor of alcoholic beverages. Select CBD Bites will be available in 30-packs, 10-packs, and 2-packs through Southern Glazer’s distribution network, as well as online.

For more information on product availability, please visit www. .

These products are not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Keep out of reach of children. Pregnant consumers should consult their physician before using these products.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer cannabis products whose mission is to improve lives by bringing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for its quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility in medical markets. and adults. In United States , Curaleaf currently operates in 23 states with 130 dispensaries, 26 cultivation sites and employs more than 5,600 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, combining pioneering science and research with state-of-the-art cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit .

Forward-looking statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “proposes”, “plans”, “intends” , “anticipates” or “believes”, or variations of these words and expressions, or by the use of words or expressions indicating that certain actions, events or results can, might, might occur or be achieved. More particularly and without limitation, this press release contains forward-looking statements and information regarding the launch of Select CBD Bites. Such forward-looking statements and information reflect the current beliefs of management and are based on assumptions made by and information currently available to the company with respect to the subject matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information on these assumptions and risks and uncertainties is contained in the “Risk Factors and Uncertainties” section of the Company’s most recently filed Annual Information Form. March 9, 2022 which is available under the Company’s SEDAR profile at , and in other filings the Company has made and may make in the future with applicable securities authorities. The forward-looking statements contained herein are made only as of the date of this press release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place significant reliance on any forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved of the contents of this press release.

Curaleaf Holdings, Inc.
[email protected]

Curaleaf Holdings, Inc.
Tracy Brady vice president of corporate communications
[email protected]com

Quote See original content to download multimedia:

SOURCE Curaleaf Holdings, Inc.

Michael P. Boser